Navarro-Ramirez R, Lang G, Moriguchi Y, Elowitz E, Corredor JAlfredo, Avila MJ, Gotfryd A, Alimi M, Gandevia L, Härtl R.
2017.
Are Locked Facets a Contraindication for Extreme Lateral Interbody Fusion? World Neurosurg. 100:607-618.
Lange CJ, Thimmappa NDeepa, Boddu SR, Dutruel SP, Pei M, Farooq Z, Behzadi AHeshmatzad, Wang Y, Zabih R, Prince MR.
2017.
Automating Perforator Flap MRA and CTA Reporting.. J Digit Imaging. 30(3):350-357.
A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..
2017.
Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..
2017.
Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
Singh H, Essayed WI, Jada A, Moussazadeh N, Dhandapani S, Rote S, Schwartz TH.
2017.
Contralateral supraorbital keyhole approach to medial optic nerve lesions: an anatomoclinical study.. J Neurosurg. 126(3):940-944.
Falavigna A, Dozza DCassol, Teles AR, Wong CChek, Barbagallo G, Brodke D, Al-Mutair A, Ghogawala Z, K Riew D.
2017.
Current Status of Worldwide Use of Patient-Reported Outcome Measures (PROMs) in Spine Care.. World Neurosurg. 108:328-335.